Jay Clayton, OTR/L, CHT in Basalt, CO - Medicare Occupational Therapy Provider

Jay Clayton, OTR/L, CHT is a medicare enrolled "Occupational Therapist - Hand" provider in Basalt, Colorado. He graduated from medical school in 1998 and has 26 years of diverse experience with area of expertise as Occupational Therapy. He is a member of the group practice Vail Clinic Inc and his current practice location is 200 Robinson St Ste D300, Basalt, Colorado. You can reach out to his office (for appointments etc.) via phone at (970) 476-1225.

Jay Clayton is licensed to practice in South Dakota (license number 0444) and he also participates in the medicare program. He accepts medicare assignments (which means he accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and his NPI Number is 1003997982.

Contact Information

	Jay Clayton, OTR/L, CHT
	200 Robinson St Ste D300, Basalt, CO 81621-8474
	(970) 476-1225
	Not Available

Healthcare Provider's Profile

Full Name	Jay Clayton
Gender	Male
Speciality	Occupational Therapy
Experience	26 Years
Location	200 Robinson St Ste D300, Basalt, Colorado
Accepts Medicare Assignments	Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.

Medical Education and Training:

Jay Clayton graduated from medical school in 1998

NPI Data:

NPI Number: 1003997982
Provider Enumeration Date: 10/18/2006
Last Update Date: 02/07/2023

Medicare PECOS Information:

PECOS PAC ID: 6305733882
Enrollment ID: I20230220000580

Medical Identifiers

Medical identifiers for Jay Clayton such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1003997982	NPI	-	NPPES
35144	Other	IA	WELLMARK

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
225XH1200X	Occupational Therapist - Hand	0444 (South Dakota)	Primary

Group Practice Association

Group Practice Name	Group PECOS PAC ID	No. of Members
Vail Clinic Inc	3577475714	164

News Archive

First drug for Huntington's disease approved for use in the U.S.

Huntington's disease is a fatal, inherited neurodegenerative disorder for which there is no cure and usually affects people in their 30s and 40s, but some patients are affected as early as childhood, while others aren't affected until they are older.

First study to measure minute changes in breast tumor connective tissue fibers

Using advanced microscopes equipped with tissue-penetrating laser light, cancer imaging experts at Johns Hopkins have developed a promising, new way to accurately analyze the distinctive patterns of ultra-thin collagen fibers in breast tumor tissue samples and to help tell if the cancer has spread.

Scientific Learning introduces new series of Virtual Brain Seminars for students

In today's economy, traveling to see renowned educators and authors speak at national conferences and seminars is no longer an option for many K-12 educators. Beginning this month, however, educators will have the opportunity to hear from nationally recognized experts in education, technology and neuroscience with the launch of a new series of Virtual Brain Seminars presented by Scientific Learning, makers of the Fast ForWord and Reading Assistant family of products.

Cerapedics closes $4 million term loan, raises additional $4 million in equity financing

Cerapedics, a privately-held orthobiologics company, today announced closing of a $4 million term loan from GE Capital, Healthcare Financial Services, bringing the total facility to $16.5 million. The company also announced it recently raised an additional $4 million in equity financing from inside investors.

53 share a needle & HIV risk due to a clinic blunder

Over 50 patients at a private radiology clinic were given blood tests using a needle device meant for single-patient use. Authorities have launched an investigation into the matter. These patients are all at risk of hepatitis B, hepatitis C and HIV infection. These cancer patients will need testing for the viruses, and again in three months. They had visited the hospital for a positron emission tomography (PET) scan for cancer detection.

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Jay Clayton allows following entities to bill medicare on his behalf.

Provider Name	Vail Clinic Inc
Provider Type	Part B Supplier - Clinic/group Practice
Provider Identifiers	NPI Number: 1992812333 PECOS PAC ID: 3577475714 Enrollment ID: O20031105000224

News Archive

First drug for Huntington's disease approved for use in the U.S.

First study to measure minute changes in breast tumor connective tissue fibers

Scientific Learning introduces new series of Virtual Brain Seminars for students

Cerapedics closes $4 million term loan, raises additional $4 million in equity financing

53 share a needle & HIV risk due to a clinic blunder

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Jay Clayton is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Jay Clayton, OTR/L, CHT Po Box 40000, Vail, CO 81658-7520 Ph: (704) 762-4519	Jay Clayton, OTR/L, CHT 200 Robinson St Ste D300, Basalt, CO 81621-8474 Ph: (970) 476-1225

News Archive

First drug for Huntington's disease approved for use in the U.S.

First study to measure minute changes in breast tumor connective tissue fibers

Scientific Learning introduces new series of Virtual Brain Seminars for students

Cerapedics closes $4 million term loan, raises additional $4 million in equity financing

53 share a needle & HIV risk due to a clinic blunder

Occupational Therapist in Basalt, CO

Willa Bonzi, MOT, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 327 Allison Ln, Basalt, CO 81621 Phone: 970-729-0387
Marissa P Meinema, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 129 Gardener Way, Basalt, CO 81621 Phone: 517-404-0204
Sean P Vetter, OTR-L-CHT Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 200 Robinson St Ste D300, Basalt, CO 81621 Phone: 970-476-1225
Jeannine T Rembold, OTR-L, CHT Occupational Therapist Medicare: Accepting Medicare Assignments Practice Location: 200 Robinson St Ste D300, Basalt, CO 81621 Phone: 970-476-1225

Jay Clayton, OTR/L, CHT - Medicare Occupational Therapist in Basalt, CO

Contact Information

Healthcare Provider's Profile

Medical Identifiers

Medical Taxonomies and Licenses

Group Practice Association

First drug for Huntington's disease approved for use in the U.S.

First study to measure minute changes in breast tumor connective tissue fibers

Scientific Learning introduces new series of Virtual Brain Seminars for students

Cerapedics closes $4 million term loan, raises additional $4 million in equity financing

53 share a needle & HIV risk due to a clinic blunder

Medicare Reassignments

First drug for Huntington's disease approved for use in the U.S.

First study to measure minute changes in breast tumor connective tissue fibers

Scientific Learning introduces new series of Virtual Brain Seminars for students

Cerapedics closes $4 million term loan, raises additional $4 million in equity financing

53 share a needle & HIV risk due to a clinic blunder

Medicare Part D Prescriber Enrollment

Mailing Address and Practice Location

First drug for Huntington's disease approved for use in the U.S.

First study to measure minute changes in breast tumor connective tissue fibers

Scientific Learning introduces new series of Virtual Brain Seminars for students

Cerapedics closes $4 million term loan, raises additional $4 million in equity financing

53 share a needle & HIV risk due to a clinic blunder

Occupational Therapist in Basalt, CO